Company Performance Metrics
CelCyr provides AI-powered clinical trial optimisation and consulting services for early-stage drug development. The company focuses on Phase I and Phase II studies, using deep learning, predictive modelling, and data engineering to support trial design, patient stratification, recruitment, biomarker validation, and real-time patient monitoring.
Its platform offers analytics and insights such as predictive site performance, investigator matching, retention prediction, and anomaly detection. CelCyr also delivers documentation support through AI-assisted scientific insight generation, automated report drafting, and protocol compliance checks. In addition to technology solutions, it offers strategic management support, fractional CMO services, advisory board coordination, and startup-focused guidance for clinical and product development decisions. CelCyr serves early-stage and growth-stage biotech and life sciences companies working across prevalent and rare disease indications.
